These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33341307)

  • 21. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
    Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
    Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
    Huang Y; Hajishengallis G; Michalek SM
    Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.
    Ferreira RB; Valdez Y; Coombes BK; Sad S; Gouw JW; Brown EM; Li Y; Grassl GA; Antunes LC; Gill N; Truong M; Scholz R; Reynolds LA; Krishnan L; Zafer AA; Sal-Man N; Lowden MJ; Auweter SD; Foster LJ; Finlay BB
    mBio; 2015 Sep; 6(5):e01421-15. PubMed ID: 26396246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and protective efficacy of a Salmonella Enteritidis sptP mutant as a live attenuated vaccine candidate.
    Lin Z; Tang P; Jiao Y; Kang X; Li Q; Xu X; Sun J; Pan Z; Jiao X
    BMC Vet Res; 2017 Jun; 13(1):194. PubMed ID: 28646853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen.
    Kong Q; Liu Q; Roland KL; Curtiss R
    Infect Immun; 2009 Dec; 77(12):5572-82. PubMed ID: 19805538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of host immune responses by oral vaccination to Salmonella enterica serovar Typhimurium harboring both FliC and FljB flagella.
    Eom JS; Seok Kim J; Im Jang J; Kim BH; Young Yoo S; Hyeon Choi J; Bang IS; Lee IS; Keun Park Y
    PLoS One; 2013; 8(9):e74850. PubMed ID: 24069357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
    Negi VD; Singhamahapatra S; Chakravortty D
    Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and functional characterization of Salmonella enterica serovar typhimurium poxA gene: effect on attenuation of virulence and protection.
    Kaniga K; Compton MS; Curtiss R; Sundaram P
    Infect Immun; 1998 Dec; 66(12):5599-606. PubMed ID: 9826331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmonella Typhimurium lacking phoBR as a live vaccine candidate against poultry infection.
    Jung B; Park S; Kim E; Yoon H; Hahn TW
    Vet Microbiol; 2022 Mar; 266():109342. PubMed ID: 35063827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-flagellin antibody responses elicited in mice orally immunized with attenuated Salmonella enterica serovar Typhimurium vaccine strains.
    Massis LM; Braga CJ; Sbrogio-Almeida ME; Lauand C; Newton SM; Klebba PE; Ferreira LC
    Mem Inst Oswaldo Cruz; 2008 Sep; 103(6):606-10. PubMed ID: 18949334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes.
    Matsui H; Fukiya S; Kodama-Akaboshi C; Eguchi M; Yamamoto T
    J Med Microbiol; 2015 Mar; 64(Pt 3):295-302. PubMed ID: 25589672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
    Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT
    J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection.
    Pesciaroli M; Aloisio F; Ammendola S; Pistoia C; Petrucci P; Tarantino M; Francia M; Battistoni A; Pasquali P
    Vaccine; 2011 Feb; 29(9):1783-90. PubMed ID: 21219981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of transmissible gastroenteritis virus (TGEV) M gene delivered by attenuated Salmonella typhimurium in mice.
    Qing Y; Liu J; Huang X; Li Y; Zhang Y; Chen J; Wen X; Cao S; Wen Y; Wu R; Yan Q; Ma X
    Virus Genes; 2016 Apr; 52(2):218-27. PubMed ID: 26837896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of pigs to prevent disease in humans: construction and protective efficacy of a Salmonella enterica serovar Typhimurium live negative-marker vaccine.
    Selke M; Meens J; Springer S; Frank R; Gerlach GF
    Infect Immun; 2007 May; 75(5):2476-83. PubMed ID: 17296750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
    Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
    Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.